Ferrari heir establishes trust for supercar firm stake

Autocar Professional BureauBy Autocar Professional Bureau calendar 21 Dec 2022 Views icon7829 Views Share - Share to Facebook Share to Twitter Share to LinkedIn Share to Whatsapp
Ferrari heir establishes trust for supercar firm stake

Piero Ferrari, son of founder Enzo and Ferrari's second-largest shareholder, put in place a family trust this month to manage his 10 percent stake in the Italian luxury sports carmaker, as per Reuters, citing a US regulatory filing.

The move outlines succession plans in relation to the group's shareholding structure.

Piero Ferrari's daughter Antonella, as well as his grandsons Enzo Mattioli Ferrari and Piero Galassi Ferrari, have been named trust beneficiaries.

According to the filing, the trust is "an instrument useful to preserve the unity" of Piero Ferrari's current participatory interest in Ferrari.

Piero Ferrari, 77, has transferred "bare ownership" of the trust's shares, which are worth around 4 billion euros ($4.2 billion) at current prices. He will keep his voting rights in the company, which are greater than 15%.

The move has no bearing on Piero Ferrari's current consultation agreement with Exor, the holding company of Italy's Agnelli family. Dutch-based.

Exor, owns approximately 23% of Ferrari and approximately 35 percent of voting rights.

According to Reuters, Ferrari and Exor both declined to comment.

RELATED ARTICLES
Suzuki Motorcycle Opens First Dealership in Leh, Completing India Presence

auther Angitha Suresh calendar04 May 2026

The inauguration of Mentokling Suzuki in Leh gives the two-wheeler manufacturer a foothold in every state and union terr...

Autocar Professional's May 1, 2026 Edition is out!

auther Autocar Professional Bureau calendar04 May 2026

This edition of Autocar Professional turns its lens on one of the most consequential, yet under-examined, dimensions of ...

Exide’s Cylindrical Cell Lines to Start Customer Sample Deliveries by Q1FY27

auther Darshan Nakhwa calendar04 May 2026

The company said the prismatic cell line will initiate product trials shortly thereafter.